The influence of the-94 Ins/Del ATTG polymorphism of NFkB on the anti-CCP antibody levels in patients with rheumatoid arthritis

被引:1
|
作者
Fabiola Ayon-Perez, Miriam [1 ]
Joseph Topete-Cordoba, Jonathan [2 ]
Manuel Agraz-Cibrian, Juan [1 ,2 ]
Ortiz-Martinez, Liliana [3 ]
De Jesus Duran-Avelar, Ma [1 ]
Vazquez-Reyes, Alejandro [1 ]
Vibanco-Perez, Norberto [1 ]
Gutierrez-Franco, Jorge [1 ]
Francisco Zambrano-Zaragoza, Jose [1 ,2 ]
机构
[1] Univ Autonoma Nayarit, Unidad Academ Ciencias Quim Biol & Farmaceut, Tepic 63117, Nayarit, Mexico
[2] Univ Autonoma Nayarit, Salud Publ, Tepic, Nayarit, Mexico
[3] Inst Mexican Segura Social HGZ 1, Clin Reumatol, Serv Med Interne, Tepic, Nayarit, Mexico
关键词
anti-CCP; NF-kB; polymorphism; rheumatoid arthritis; KAPPA-B; DISEASE-ACTIVITY; PROMOTER REGION; PATHOGENESIS; RISK; SUSCEPTIBILITY; ASSOCIATION; CYTOKINES; INCREASES; PATHWAY;
D O I
10.1097/MD.0000000000028301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is an autoimmune disease characterized by an inflammatory process that affects mainly synovial tissue in joints, and by the production of cyclic citrullinated peptides (anti-CCP) antibodies. In the inflammatory process the regulation of the nuclear factor kappa B (NFkB) transcription factor activation is a key point in the production of inflammatory cytokines. On the other hand, polymorphisms in several genes could contribute to the promotion of the inflammatory process observed in RA, and the association of the rs28362491 polymorphism in the NFkB gene with RA has been studied in different population. Therefore, it could be one of the interest targets to analyze their association with RA in a Mexican population. This is a case-control study to determine the influence of rs28362491 in the NFkB gene on RA and on clinical features of this disease, such as anti-CCP antibody levels, Disease Activity Score, and Health Assessment Questionnaire-Disability Index. The genotype of rs28362491 in the NFkB gene was determined in 140 RA patients and 135 healthy controls using the polymerase chain reaction-restriction fragment length polymorphism method with the enzyme PflMI. The following clinical variables were also determined: anti-CCP levels, Disease Activity Score, and Spanish version of the Health Assessment Questionnaire Disability-Index. Although no association of the polymorphism as a risk/protection factor with RA was found, the RA patients who carried the Ins/Ins genotype showed higher anti-CCP levels, while those with the Del/Del genotype showed higher Spanish version of the Health Assessment Questionnaire-Disability Index levels, compared to the other genotypes. The NFkB -94 Ins/Del ATTG (rs28362491) polymorphism is, therefore, associated with higher levels of anti-CCP antibodies, though no significant association as a risk or protection factor in RA cases was identified.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Lack of effect of rapamycin in anti-CCP antibody production in a rheumatoid arthritis kidney allograft recipient
    Lopez-Hoyos, M
    Rodrigo, E
    Fernandez-Fresnedo, G
    Martinez-Taboada, VM
    Valero, R
    Arias, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (04) : 529 - 531
  • [42] The association between NFKB1-94ins/del ATTG polymorphism and non-small cell lung cancer risk in a Chinese Han population
    Wang, Yue
    Chen, Libo
    Pan, Liming
    Xue, Jinru
    Yu, Haixiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 8153 - 8157
  • [43] Relationship between NF-κB1-94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients
    Zahednasab, Hamid
    Mesbah-Namin, Seyed Alireza
    Sahraian, Mohammad Ali
    Balood, Mohammad
    Doosti, Rozita
    NEUROSCIENCE LETTERS, 2013, 545 : 46 - 49
  • [44] NFKB1 promoter –94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients
    Samy Y. Elkhawaga
    Maher H. Gomaa
    Mohsen M. Elsayed
    Ahmed A. Ebeed
    Clinical Rheumatology, 2021, 40 : 2927 - 2937
  • [45] The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates
    Zintzaras, Elias
    Papathanasiou, Afroditi A.
    Ziogas, Dimitrios C.
    Voulgarelis, Michael
    BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [46] Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis
    Rojas-Villarraga, Adriana
    Diaz, Francisco J.
    Calvo-Paramo, Enrique
    Salazar, Juan C.
    Iglesias-Gamarra, Antonio
    Mantilla, Ruben D.
    Anaya, Juan-Manuel
    JOURNAL OF AUTOIMMUNITY, 2009, 32 (01) : 64 - 69
  • [47] ANTIBODIES TO ANTI-CCP, RHEUMATOID FACTOR AND MARKERS OF INFLAMMATION, AS THE MAIN DIAGNOSTIC PARAMETERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Zhdan, V. M.
    Tkachenko, M. V.
    Babanina, M. Yu.
    Zherebkin, V. V.
    Volchenko, H. V.
    Kitura, Ye. M.
    WORLD OF MEDICINE AND BIOLOGY, 2019, 68 (02): : 44 - 48
  • [48] The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis
    Hodkinson, Bridget
    Meyer, Pieter W. A.
    Musenge, Eustasius
    Ally, Mahmood M. T.
    Wadee, Ahmed A.
    Anderson, Ronald
    Tikly, Mohammed
    CLINICAL RHEUMATOLOGY, 2010, 29 (06) : 615 - 618
  • [49] The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis
    Bridget Hodkinson
    Pieter W. A. Meyer
    Eustasius Musenge
    Mahmood M. T. Ally
    Ahmed A. Wadee
    Ronald Anderson
    Mohammed Tikly
    Clinical Rheumatology, 2010, 29 : 615 - 618
  • [50] The continuous measurement of anti-CCP-antibodies does not help to evaluate the disease activity in anti-CCP-antibody-positive patients with rheumatoid arthritis
    Landmann, Thoren
    Kehl, Gabriele
    Bergner, Raoul
    CLINICAL RHEUMATOLOGY, 2010, 29 (12) : 1449 - 1453